ReviewJMA journal2025
Artificial Intelligence Applications in Ophthalmology.
Review in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Current Applications of Artificial Intelligence for Fuchs Endothelial Corneal Dystrophy: A Systematic Review.Translational vision science & technology · 2025Pooled it
- Future visual field prediction in glaucoma: an application of first-order autoregressive approach.International ophthalmology · 2026Article
- Current Applications of Artificial Intelligence in Neuro-Ophthalmic Imaging: A Narrative Approach.Medical sciences (Basel, Switzerland) · 2026Review
- Artificial Intelligence Applications in Sickle Cell Retinopathy Imaging: Current Progress, Challenges, and Future Directions.Journal of ophthalmology · 2026Review
- AI-Assisted Detection of Macular OCT Abnormalities by Optometrists: A Retrospective Reader Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- How does artificial intelligence improve ophthalmology education outcomes?-The mediating role of learning motivation and self-efficacy.Frontiers in psychology · 2026Article
- Article
- Perceived Trust in Artificial Intelligence in Eye Care: Demographic Determinants and Variations in Attitudes Among Ophthalmologists and Residents.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Social Media and Telemedicine in Ophthalmology: Misinformation, Patient Perception, and the Evolving Digital Patient.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Autoimmune Diseases of the Eyelid Skin: Molecular Pathways, Clinical Manifestations, and Therapeutic Insights.International journal of molecular sciences · 2025Review
- Article
- Imaging biomarkers in ophthalmology: hype, hope or game-changer?BMJ open ophthalmology · 2025Article
- Article
- Artificial intelligence for posterior capsule opacification.Frontiers in medicine · 2025Review
- Clinical performance of an interactive platform based on artificial intelligence in ophthalmology: experience in a third-level reference center.Frontiers in medicine · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ophthalmology is well suited for the integration of artificial intelligence (AI) owing to its reliance on various imaging modalities, such as anterior segment photography, fundus photography, and optical coherence tomography (OCT), which generate large volumes of high-resolution digital images. These images provide rich datasets for training AI algorithms, which enables precise diagnosis and monitoring of various ocular conditions. Retinal disease management heavily relies on image recognition. Limited access to ophthalmologists in underdeveloped areas and high image volumes in developed countries make AI a promising, cost-effective solution for screening and diagnosis. In corneal diseases, differential diagnosis is critical yet challenging because of the wide range of potential etiologies. AI and diagnostic technologies offer promise for improving the accuracy and speed of these diagnoses, including the differentiation between infectious and noninfectious conditions. Smartphone imaging coupled with AI technology can advance the diagnosis of anterior segment diseases, democratizing access to eye care and providing rapid and reliable diagnostic results. Other potential areas for AI applications include cataract and vitreous surgeries as well as the use of generative AI in training ophthalmologists. While AI offers substantial benefits, challenges remain, including the need for high-quality images, accurate manual annotations, patient heterogeneity considerations, and the "black-box phenomenon". Addressing these issues is crucial for enhancing the effectiveness of AI and ensuring its successful integration into clinical practice. AI is poised to transform ophthalmology by increasing diagnostic accuracy, optimizing treatment strategies, and improving patient care, particularly in high-risk or underserved populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.